Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 577

1.

A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.

Buchert R, Thomasius R, Wilke F, Petersen K, Nebeling B, Obrocki J, Schulze O, Schmidt U, Clausen M.

Am J Psychiatry. 2004 Jul;161(7):1181-9.

PMID:
15229049
[PubMed - indexed for MEDLINE]
2.

Long-term effects of "ecstasy" use on serotonin transporters of the brain investigated by PET.

Buchert R, Thomasius R, Nebeling B, Petersen K, Obrocki J, Jenicke L, Wilke F, Wartberg L, Zapletalova P, Clausen M.

J Nucl Med. 2003 Mar;44(3):375-84.

PMID:
12621003
[PubMed - indexed for MEDLINE]
Free Article
3.

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.

Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt A.

Psychopharmacology (Berl). 2003 Apr;167(1):85-96. Epub 2003 Mar 11.

PMID:
12632248
[PubMed - indexed for MEDLINE]
4.

Ecstasy-induced reduction of the availability of the brain serotonin transporter as revealed by [11C](+)McN5652-PET and the multi-linear reference tissue model: loss of transporters or artifact of tracer kinetic modelling?

Buchert R, Thiele F, Thomasius R, Wilke F, Petersen K, Brenner W, Mester J, Spies L, Clausen M.

J Psychopharmacol. 2007 Aug;21(6):628-34. Epub 2006 Nov 8.

PMID:
17092972
[PubMed - indexed for MEDLINE]
5.

Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.

Buchert R, Obrocki J, Thomasius R, V├Ąterlein O, Petersen K, Jenicke L, Bohuslavizki KH, Clausen M.

Nucl Med Commun. 2001 Aug;22(8):889-97.

PMID:
11473208
[PubMed - indexed for MEDLINE]
6.

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.

Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.

J Psychopharmacol. 2006 Mar;20(2):211-25. Review.

PMID:
16510479
[PubMed - indexed for MEDLINE]
7.

In vivo detection of short- and long-term MDMA neurotoxicity--a positron emission tomography study in the living baboon brain.

Scheffel U, Szabo Z, Mathews WB, Finley PA, Dannals RF, Ravert HT, Szabo K, Yuan J, Ricaurte GA.

Synapse. 1998 Jun;29(2):183-92.

PMID:
9593108
[PubMed - indexed for MEDLINE]
8.

Reversibility of ecstasy-induced reduction in serotonin transporter availability in polydrug ecstasy users.

Buchert R, Thomasius R, Petersen K, Wilke F, Obrocki J, Nebeling B, Wartberg L, Zapletalova P, Clausen M.

Eur J Nucl Med Mol Imaging. 2006 Feb;33(2):188-99. Epub 2005 Aug 17.

PMID:
16133393
[PubMed - indexed for MEDLINE]
9.

Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender.

de Win MM, Reneman L, Reitsma JB, den Heeten GJ, Booij J, van den Brink W.

Psychopharmacology (Berl). 2004 May;173(3-4):376-82. Epub 2004 Jan 15.

PMID:
14726997
[PubMed - indexed for MEDLINE]
10.

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users.

Semple DM, Ebmeier KP, Glabus MF, O'Carroll RE, Johnstone EC.

Br J Psychiatry. 1999 Jul;175:63-9.

PMID:
10621770
[PubMed - indexed for MEDLINE]
11.

Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings.

Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J.

Arch Gen Psychiatry. 2001 Oct;58(10):901-6.

PMID:
11576026
[PubMed - indexed for MEDLINE]
12.

Positron emission tomography imaging of serotonin transporters in the human brain using [11C](+)McN5652.

Szabo Z, Kao PF, Scheffel U, Suehiro M, Mathews WB, Ravert HT, Musachio JL, Marenco S, Kim SE, Ricaurte GA, et al.

Synapse. 1995 May;20(1):37-43.

PMID:
7624828
[PubMed - indexed for MEDLINE]
13.

Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons.

Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W.

Lancet. 2001 Dec 1;358(9296):1864-9.

PMID:
11741626
[PubMed - indexed for MEDLINE]
14.
15.

Positron emission tomography imaging of the serotonin transporter in subjects with a history of alcoholism.

Szabo Z, Owonikoko T, Peyrot M, Varga J, Mathews WB, Ravert HT, Dannals RF, Wand G.

Biol Psychiatry. 2004 Apr 1;55(7):766-71.

PMID:
15039007
[PubMed - indexed for MEDLINE]
16.

Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652.

Frankle WG, Lombardo I, New AS, Goodman M, Talbot PS, Huang Y, Hwang DR, Slifstein M, Curry S, Abi-Dargham A, Laruelle M, Siever LJ.

Am J Psychiatry. 2005 May;162(5):915-23.

PMID:
15863793
[PubMed - indexed for MEDLINE]
17.
18.

Brain serotonin transporter binding in former users of MDMA ('ecstasy').

Selvaraj S, Hoshi R, Bhagwagar Z, Murthy NV, Hinz R, Cowen P, Curran HV, Grasby P.

Br J Psychiatry. 2009 Apr;194(4):355-9. doi: 10.1192/bjp.bp.108.050344.

PMID:
19336788
[PubMed - indexed for MEDLINE]
Free Article
19.

Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.

Kish SJ, Lerch J, Furukawa Y, Tong J, McCluskey T, Wilkins D, Houle S, Meyer J, Mundo E, Wilson AA, Rusjan PM, Saint-Cyr JA, Guttman M, Collins DL, Shapiro C, Warsh JJ, Boileau I.

Brain. 2010 Jun;133(Pt 6):1779-97. doi: 10.1093/brain/awq103. Epub 2010 May 17.

PMID:
20483717
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)C]McN 5652.

Simpson HB, Lombardo I, Slifstein M, Huang HY, Hwang DR, Abi-Dargham A, Liebowitz MR, Laruelle M.

Biol Psychiatry. 2003 Dec 15;54(12):1414-21.

PMID:
14675806
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk